UP!

CRI $73.86

CRI target price
73.86
0
0
Carter's, Inc.
Type
Public
Traded as NYSE: CRI
S&P 400 Component
Founded  1865 (1865-MM)
Founder William Carter
Headquarters Atlanta, Georgia, U.S.
Number of locations
654 (January 2017)
Products Clothing
Subsidiaries OshKosh B'Gosh
Website www.carters.com

Carter's, Inc., also known as the William Carter Company, is a major American designer and marketer of children's apparel. It was founded in 1865 by William Carter. Carter's acquired competitor OshKosh B'Gosh for $312 million in 2005.

William Carter was the founder of William Carter Company in 1865 in Needham, Massachusetts. William Carter (1830–1918) was born in Alfreton, Derbyshire, England. He arrived in America on January 28, 1857. He married Martha Lee (1842-1873). They had four children: William Henry Carter (1864–1955), who served two terms in the U.S. House of Representatives (1915-1919) prior to being elected president of the William Carter Company in 1918; Mary Elizabeth Carter (1865-1961); John J. Carter (1867-1939); and Horace A. Carter (1869-1959). By the early 1960s, the William Carter Company manufactured at seven mills in Massachusetts and the south. The Carter family sold the business in 1990.[1]

In 2012, Carter's, Inc. announced that Braselton, Georgia would receive their one-million-square-foot, $50 million distribution center that will support their e-commerce, retail, and wholesale businesses. The company hopes to create 1,000 jobs at the facility by 2015.

In February 2017, Carter's, Inc. acquired Skip Hop Inc., an infant and child product company based in New York, for $140 million in cash and up to $10 million in future payments contingent on reaching certain financial goals in 2017. Fireman Capital Partners, a private equity firm, had previously acquired a majority equity stake in Skip Hop Inc. for $50 million in November 2013.

In October 2012 the Atlanta Business Chronicle reported that Carter's Inc. was likely to lease in the Phipps Tower in Buckhead for its headquarters. In December 2012 Carter's Inc. announced that it was moving its headquarters from Midtown Atlanta. The lease of 222,730 square feet (20,692 m) of space is one of the largest headquarters leases to have occurred to date in the Buckhead area of Atlanta. The estimated value of the lease, except for concessions and escalation, was $70 million. The lease in Midtown was scheduled to be terminated on December 31, 2013.

The company consolidated its out of state jobs into the new facility, with 200 additional jobs going to Buckhead. Manulife Financial Corp owns both the Proscenium and the Phipps Tower so Carter's terminated its lease early in one building and moved to the other.

The company now has its headquarters in Suite 1800 at Phipps Tower, in Buckhead, Atlanta.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-10-27 Future report Set alerts
Q2 2022 2022-07-29 1.30 1.30
Q1 2022 2022-04-29 1.66 1.66
Q4 2021 2022-02-25 2.31 2.31
Q3 2021 2021-10-29 1.93 1.93
Q2 2021 2021-07-30 1.67 1.67
Q1 2021 2021-04-30 1.98 1.98
Q4 2020 2021-02-26 2.46 2.46
Q3 2020 2020-10-23 0.00 0.00
Q2 2020 2020-07-24 0.54 0.19

Ratings

2016-07-13 Initiated Coverage Cowen and Company Market Perform
2016-06-01 Reiterated Rating Citigroup Inc. Neutral
2016-04-29 Boost Price Target FBR & Co. Outperform $104.00 to $111.00
2016-04-29 Boost Price Target FBR & Co Outperform $104.00 to $111.00
2016-04-10 Reiterated Rating Goldman Sachs Buy $122.00 to $127.00
2016-04-10 Reiterated Rating Goldman Sachs Group Inc. Buy $122.00 to $127.00
2016-02-26 Reiterated Rating FBR & Co. Buy $104.00
2016-02-26 Reiterated Rating Piper Jaffray Hold $96.00 to $97.00
2016-02-26 Reiterated Rating Piper Jaffray Cos. Hold $96.00 to $97.00
2016-01-04 Upgrade Oppenheimer Market Perform to Outperform $90.00 to $108.00
2016-01-04 Upgrade Oppenheimer Holdings Inc. Market Perform to Outperform $90.00 to $108.00
2015-12-17 Downgrade Citigroup Inc. Buy to Neutral
2015-12-07 Reiterated Rating Oppenheimer Hold $90.00
2015-11-26 Initiated Coverage FBR & Co. Market Perform $54.00
2015-10-22 Initiated Coverage Wells Fargo Outperform
2015-10-22 Initiated Coverage Wells Fargo & Co. Outperform
2015-09-16 Downgrade Piper Jaffray Overweight to Neutral $116.00 to $105.00
2015-08-03 Reiterated Rating Piper Jaffray Buy $116.00
2015-07-14 Reiterated Rating Oppenheimer Market Perform $100.00
2015-07-02 Reiterated Rating Sterne Agee CRT Neutral
2015-07-02 Reiterated Rating Piper Jaffray Buy $110.00 to $116.00
2015-07-01 Reiterated Rating Goldman Sachs Conviction-Buy to Buy $115.00 to $127.00
2015-06-26 Downgrade Sterne Agee CRT Neutral $105.00
2015-06-18 Downgrade Sterne Agee CRT Buy to Neutral $105.00
2015-06-09 Set Price Target Piper Jaffray Buy $110.00
2015-04-30 Boost Price Target Citigroup Inc. Buy $107.00 to $114.00
2015-04-30 Boost Price Target Oppenheimer Market Perform $85.00 to $100.00
2015-04-29 Set Price Target Sterne Agee CRT Buy $94.00 to $105.00
2015-03-24 Reiterated Rating Citigroup Inc. Buy $100.00 to $107.00
2015-02-27 Boost Price Target Citigroup Inc. Buy $99.00 to $100.00
2015-02-27 Boost Price Target FBR & Co. Outperform $90.00 to $96.00
2014-11-13 Initiated Coverage Sterne Agee CRT Buy $91.00
2014-10-24 Reiterated Rating Citigroup Inc. Buy $95.00 to $94.00
2014-10-20 Reiterated FBR Capital Outperform $85 to $90
2014-10-20 Boost Price Target FBR & Co. Outperform $85.00 to $90.00
2014-10-15 Reiterated Rating Goldman Sachs Buy to Conviction-Buy
2014-08-26 Reiterated Rating Citigroup Inc. Buy $93.00 to $95.00
2014-07-22 Reiterated Rating Goldman Sachs Buy
2014-06-20 Initiated Coverage Wells Fargo & Co. Market Perform
2014-06-20 Initiated Coverage Wells Fargo Market Perform
2014-04-02 Upgrade Piper Jaffray Neutral to Overweight $74.00 to $92.00
2014-01-07 Boost Price Target FBR & Co. Outperform to Market Perform $82.00 to $85.00
2013-11-19 Initiated Coverage Stephens Overweight
2013-10-01 Upgrade Goldman Sachs Neutral to Buy $77.00 to $89.00
2012-11-01 Reiterated FBR Capital Mkt Perform $52 to $54
2012-05-15 Initiated FBR Capital Mkt Perform $54
2012-04-26 Upgrade BB&T Capital Mkts Hold to Buy
2011-04-28 Downgrade BB&T Capital Mkts Buy to Hold
2010-03-12 Initiated BB&T Capital Mkts Buy $36
2010-03-12 Initiated
2009-10-20 Initiated BMO Capital Markets Outperform $33
2008-10-22 Upgrade Sterne Agee Hold to Buy $20 to $22
2016-07-13 Initiated Coverage Cowen and Company Market Perform
2016-06-01 Reiterated Rating Citigroup Inc. Neutral
2016-04-29 Boost Price Target FBR & Co. Outperform $104.00 to $111.00
2016-04-29 Boost Price Target FBR & Co Outperform $104.00 to $111.00
2016-04-10 Reiterated Rating Goldman Sachs Buy $122.00 to $127.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
CASEY MICHAEL DENNIS Chief Executive Officer 0.73%  (386513) CRI / TFM /
Lynch Brian President, Carter\'s, Inc. 0.13%  (71104) CRI /
WELCH JOHN R 0.13%  (71063) CRI /
FULTON PAUL 0.13%  (68016) BSET / CRI /
Westenberger Richard F. Chief Financial Officer 0.11%  (58363) CRI /
WHIDDON THOMAS E 0.10%  (52849) CRI / DLTR / SON /
Fitzgerald Lisa EVP Brand Leader 0.09%  (49899) CRI /
Rork Christopher EVP of Supply Chain 0.07%  (38722) CRI /
Williams Jeffrey B. Senior VP Retail 0.06%  (30839) CRI /
Montgoris William J 0.06%  (30302) CRI /
Corning Kevin Doyle EVP International 0.06%  (30229) CRI /
Gibbons Brendan M. SVP General Counsel & Secretar 0.05%  (28786) CRI / GOLF / WWW /
Foglesong Greg SVP - Marketing 0.05%  (27530) CRI /
Evans Lisa EVP and Brand Leader 0.05%  (25636) CRI / GMAN /
CASTAGNA VANESSA J 0.04%  (22505) CRI /
BRINKLEY AMY WOODS 0.04%  (21747) CRI / ROP /
PETTY JAMES C Former President Retail Stores 0.04%  (20750) CRI /
Wilson Jill SVP Human Resources 0.04%  (19828) CRI /
D'Emilio Julie Senior Vice President - Sales 0.04%  (18959) CRI /
Smith Peter Royer EVP Supply Chain 0.03%  (18360) CRI /
Wu Michael C. SVP, General Counsel & Secy 0.02%  (12076) CRI / RST /
CLEVERLY A BRUCE 0.02%  (10150) CRI /
Eagle Jevin 0.02%  (10111) CRI /
Moore Patrick Q EVP Strategy and Bus Dev 0.01%  (6732) CRI / IPG / RHP /
Buonfantino Giuseppina 0.01%  (4086) CRI /